CXCL12 and ovarian cancer: Moreover, OVCAR-5 CXCR4+CD133+ cells migrated toward the CXCR4 ligand CXCL12, were less sensitive to the most popular chemotherapeutic agent utilized in ovarian cancer, cisplatin, and over expressed the drug resistance transporter ABCG2.